MindMed posts strong cash position, progress on LSD treatment
The company has begun testing its LSD-based anxiety treatment in late-stage trials as it builds toward potential FDA approval.
The post MindMed posts strong cash position, progress on LSD treatment appeared first on Green Market Report.
